ORBi: BLETARD Noëlla - Cancer du sein: importance de la nomenclature anatomo-pathologique

Reference : Cancer du sein: importance de la nomenclature anatomo-pathologique


	Document type :	Scientific journals : Article
	Discipline(s) :	Human health sciences : Oncology
	To cite this reference:	http://hdl.handle.net/2268/108844

Title :	Cancer du sein: importance de la nomenclature anatomo-pathologique
Language :	French
Alternative title :	[en] Breast carcinoma: the interest of pathological classification
Author, co-author :	BLETARD, Noëlla [Centre Hospitalier Universitaire de Liège - CHU > > Anatomie pathologique >]
	DETREMBLEUR, Nancy [Centre Hospitalier Universitaire de Liège - CHU > > Anatomie pathologique >]
	SCAGNOL, Irène [Centre Hospitalier Universitaire de Liège - CHU > > Anatomie pathologique >]
	DELBECQUE, Katty [Centre Hospitalier Universitaire de Liège - CHU > > Anatomie pathologique >]
	DEPREZ, Manuel [Centre Hospitalier Universitaire de Liège - CHU > > Anatomie pathologique >]
	THIRY, Albert [Centre Hospitalier Universitaire de Liège - CHU > > Anatomie pathologique >]
	LAMBERT, Chantal [Centre Hospitalier Universitaire de Liège - CHU > > Anatomie pathologique >]
	MUTIJIMA NZARAMBA, Eugène [Centre Hospitalier Universitaire de Liège - CHU > > Anatomie pathologique >]
	Delvenne, Philippe [Université de Liège - ULg > Département des sciences biomédicales et précliniques > Anatomie et cytologie pathologiques >]
Publication date :	May-2011
Journal title :	Revue Médicale de Liège
Publisher :	Université de Liège. Revue Médicale de Liège
Volume :	66
Issue/season :	5-6
Pages :	261-4
Audience :	National
ISSN :	0370-629X
City :	Liège
Country :	Belgique
Keywords :	[en] Pathology ; Breast ; Carcinoma ; Immunochemistry ; Fluorescent in situ hybridization
Abstract :	[en] The breast pathology includes a large array of entities for which macroscopic and microscopic analysis remains fundamental. Tissue and cell morphology allows in most cases the distinction between benign or malignant tumours and therefore provides the clinicians with essential information for the therapeutic strategy. In the Pathology laboratory, immunohistochemistry and molecular biology have improved the specificity of the diagnosis and have introduced new prognostic and predictive markers for tumour management. The last edition of the WHO classification, released in 2003, distinguishes 21 varieties of invasive carcinoma and 2 categories of intraepithelial neoplasia based on the morphology and immunohistochemical profile. Other diseases can affect the breast, although much less frequently, such as Paget’s disease of the nipple, phyllode tumours, sarcomas, lymphomas... These diseases will not be reviewed here.
Permalink :	http://hdl.handle.net/2268/108844

File(s) associated to this reference

Fulltext file(s):

	File	Commentary	Version	Size	Access
Restricted access	CANCER DU SEIN.pdf		Publisher postprint	802.83 kB	Request copy

All documents in ORBi are protected by a user license.

Dspace v1.5